Finally, single-cell RNA sequencing analysis (scRNA-seq) was performed to validate the proportions of CD123+ dendritic cell (DC) subsets in NAFLD progression. The gene discussed is IL3RA; the disease is metabolic dysfunction-associated steatotic liver disease.